Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 179
Selected: 0
NCT IDTitle
NCT03262948Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung Cancer
NCT06525350A Study to Evaluate the Efficacy and Safety of the Combination of Glumetinib and Docetaxel(Albumin Bound)Verse Docetaxel for the Treatment of MET-overexpressed Non-small Cell Lung Cancer
NCT07798193A Study of SYH2085 Tablets Compared With Placebo in Chinese Adult Patients With Uncomplicated Influenza.
NCT06296706A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer
NCT07694843A Phase I Clinical Trial to Evaluate the Pharmacokinetic and Safety of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Mild Hepatic Impairment, Moderate Hepatic Impairment, and Normal Liver Function
NCT06941142A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer
NCT05478785A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of Cisplatin Micelle Injection (HA132) in Patients With Advanced Malignant Solid Tumors
NCT04668690Clinical Study of Mitoxantrone Hydrochloride Liposome Injection vs. Chidamide in Patients With Relapsed/Refractory PTCL
NCT05761431A Single-dose Study of Octreotide Injection in Healthy Adult Subjects
NCT04364997Study of Desvenlafaxine in Treating Major Depressive Disorder.
NCT02596373A Study of Mitoxantrone Hydrochloride Liposome Injection in Advanced Recurrent or Metastatic Breast Cancer
NCT05150626A Study to Evaluate the Effect of Different Meal Types on the Pharmacokinetics of DBPR108 in Healthy Subjects
NCT02856685A Study of Mitoxantrone Hydrochloride Liposome Infusion
NCT02070523Pegylated Liposomal Doxorubicin Versus Daunorubicin to Treat Acute Lymphoblastic Leukemia:
NCT05055791A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic Malignancies
NCT04015024A Clinical Study of SKLB1028 Capsule in the Treatment of Recurrence/Refractory AML Patients
NCT04225195Amphotericin B Cholesteryl Sulfate Complex for Injection(ABCD) in the Treatment of Invasive Candidiasis and Invasive Aspergillosis
NCT05354089A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Adults Aged 18 -59 Years.
NCT06547333A Study of CM310 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT04787328A Study of HA121-28 Tablets in Patients With Medullary Thyroid Carcinoma (MTC)
NCT04689100Efficacy and Safety of JMT101 in Patients With Advanced Solid Tumor
NCT07805135A Study of HB1801 Versus Docetaxel (Taxotere®) in Patients With Advanced Breast Cancer
NCT05100329A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced Pancreatic Cancer
NCT07623824A Phase III Clinical Trial to Evaluate the Efficacy and Safety of Octreotide Long-acting Injection in Patients With Acromegaly
NCT05715840Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)
NCT04198480A Clinical Trial to Assess the Efficacy and Safety of JMT103 in Patients With Refractory HCM
NCT05720026Study to Evaluate the Efficacy and Safety of SYSA1901 vs. Perjeta® of HER2-Positive Breast Cancer
NCT07418736A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT04218734A Study of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DM
NCT07165886Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors
NCT04927481A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced HER2 Negative Breast Cancer
NCT06957379Sirolimus for Injection (Albumin-bound) in Combination With Endocrine Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Who Have Failed Standard Therapy
NCT04900766A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Advanced Bone and Soft Tissue Sarcoma
NCT07684287A Phase 2 Study of Sirolimus for Injection (Albumin-bound) in Patients With Progressive or Symptomatic Epithelioid Hemangioendothelioma
NCT04509466Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCL
NCT04707079A Safety and Efficacy Study of Duvelisib in Relapsed/Refractory Follicular Lymphoma
NCT05089461A Study to Evaluate the Cardiac Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Malignant Tumor
NCT05901935DP303c in Patients With HER2-positive Advanced Breast Cancer
NCT05445154SKLB1028, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
NCT02043756Phase I and Pharmacokinetic Study of Mitoxantrone Hydrochloride Liposome Injection
NCT04886765A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With Osteosarcoma
NCT04811118The Comparison of the Pharmacokinetics of Albumin-bound Docetaxel and Taxotere
NCT05117658Study of HA121-28 in Patients With Non-Small Cell Lung Cancer
NCT05513664Real-World Effectiveness of Osimertinib for Patients With Non-Small Cell Lung Cancer
NCT07241936A Study of Sirolimus (Albumin-Bound) in Combination With Different ADCs Treatment of Advanced Solid Tumors
NCT04790006A Study of TG103 in Subjects With Type 2 Diabetes
NCT04161430A Study to Evaluate the Efficacy and Safety of DBPR108 100 mg in Type 2 Diabetes Mellitus Patients
NCT05761028A Study of CM310 in Subjects With Moderate to Severe Asthma
NCT03994484Study of Dosage Exploration and Pharmacokinetics for HA121-28 Tablets
NCT05097248Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of Chemotherapy